In 2010, Datamonitor estimates that there were about 6.9 million cases of hepatitis C virus in adults aged over 20 in the seven major markets. The majority of these cases (86%) were in those over age 40. Datamonitor also estimates that genotype 1b was the most prevalent genotype with 3.0 million cases, followed by genotype 1a with 1.9 million cases.
Features and benefits
- Gain insight to market potential, including a robust 10-year epidemiology forecast of hepatitis C virus prevalent cases.
- Understand the key epidemiologic risk factors associated with hepatitis C virus.
Hepatitis C virus is a predominant bloodborne disease in the seven major markets. Datamonitor estimates that the average annual growth rate of prevalent cases of hepatitis C virus in the seven major markets (the US, Japan, France, Germany, Italy, Spain, and the UK) will be 0.49%.
Your key questions answered
- What are the most robust sources for hepatitis C virus prevalence data?
- How will the patient population change over the next decade in the US, Japan, and five major EU markets (France, Germany, Italy, Spain, and the UK)?
- How do changes in population structure and risk factors affect the trend in prevalent hepatitis C virus cases?